InvestSMART

Aroa Biosurgery Limited (ASX: ARX) - Announcements

Current share price for ARX : $0.495 0.015 (2.94%)+

ASX company news and announcements for Aroa Biosurgery Limited (ARX) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Aroa Biosurgery Limited (ARX) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Aroa Biosurgery Limited (ARX), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Aroa Biosurgery Limited (ARX)

Market Cap ($m) Headline Release
date/time+
Price at
release+
Current
price+
Gain/Loss View
$171 Notification of cessation of securities - ARX 14 Feb 2024 2:13PM $0.570 $0.495 fallen by 13.16%
$171 Application for quotation of securities - ARX 14 Feb 2024 2:12PM $0.570 $0.495 fallen by 13.16%
$171 Section 708A Notice 14 Feb 2024 2:10PM $0.570 $0.495 fallen by 13.16%
$171 Investor Presentation 30 Jan 2024 8:44AM $0.720 $0.495 fallen by 31.25%
$171 December 2023 Quarterly Report and Appendix 4C 30 Jan 2024 8:43AM $0.720 $0.495 fallen by 31.25%
$171 Enivo Clinical Pilot Study 25 Jan 2024 12:53PM $0.740 $0.495 fallen by 33.11%
$171 Notification of Quarterly Results Webinar 23 Jan 2024 9:07AM $0.690 $0.495 fallen by 28.26%
$171 Notification of cessation of securities - ARX 12 Jan 2024 12:36PM $0.785 $0.495 fallen by 36.94%
$171 Aroa Half Year Results Presentation 28 Nov 2023 9:07AM $0.720 $0.495 fallen by 31.25%
$171 Aroa Biosurgery Half Yearly Results H1 FY24 28 Nov 2023 9:04AM $0.720 $0.495 fallen by 31.25%
$171 Appendix 4D and Half Year Report 28 Nov 2023 9:01AM $0.720 $0.495 fallen by 31.25%
$171 Notification of Half Year Results Webinar 22 Nov 2023 9:01AM $0.670 $0.495 fallen by 26.12%
$171 AROA Investor Event 21 Nov 2023 8:50AM $0.685 $0.495 fallen by 27.74%
$171 Bell Potter Healthcare Conference Presentation 14 Nov 2023 9:19AM $0.735 $0.495 fallen by 32.65%
$171 Investor Presentation 31 Oct 2023 8:34AM $0.745 $0.495 fallen by 33.56%
$171 September 2023 Quarterly Report and Appendix 4C 31 Oct 2023 8:29AM $0.745 $0.495 fallen by 33.56%
$171 Notification regarding unquoted securities - ARX 27 Oct 2023 4:14PM $0.758 $0.495 fallen by 34.65%
$171 Notification of Quarterly Results Webinar 24 Oct 2023 9:10AM $0.745 $0.495 fallen by 33.56%
$171 Study shows positive outcomes for Myriad in traumatic wounds 3 Oct 2023 4:34PM $0.770 $0.495 fallen by 35.71%
$171 Change of Director's Interest Notice - JM 7 Sep 2023 10:21AM $0.830 $0.495 fallen by 40.36%
$171 Application for quotation of securities - ARX 7 Sep 2023 9:00AM $0.830 $0.495 fallen by 40.36%
$171 Section 708A Notice 7 Sep 2023 8:59AM $0.830 $0.495 fallen by 40.36%
$171 Notification of cessation of securities - ARX 31 Aug 2023 10:03AM $0.860 $0.495 fallen by 42.44%
$171 Application for quotation of securities - ARX 31 Aug 2023 9:58AM $0.865 $0.495 fallen by 42.77%
$171 Section 708A Notice 31 Aug 2023 9:53AM $0.865 $0.495 fallen by 42.77%

151 - 175 of 777 results

Page 7 of 32

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.